Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioHeuris is a private agricultural biotechnology company developing gene-edited and non-transgenic crop traits for weed management. The company combines synthetic biology, computational protein engineering, breeding, gene editing, and phenotyping in an integrated platform to create herbicide-tolerance traits and related crop-management systems. Its disclosed product portfolio includes SURON for sorghum, Raizor for rice, and StrigOUT for sorghum/Striga management, with additional partnered work in soybean and cotton. BioHeuris works primarily with seed companies, breeders, growers, and agricultural partners rather than as a human therapeutics developer. The business is best classified as AgBiotech rather than life science healthcare/pharma.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioHeuris.